These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 150545)

  • 1. Inhibition of 5-hydroxytryptamine uptake by tetrahydronorharmane in vivo.
    Rommelspacher H; Strauss S; Cohnitz CH
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):229-33. PubMed ID: 150545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for inhibition of the reuptake of 5-hydroxytryptamine and noradrenaline by tetrahydronaphthylamine in rat brain.
    Bruinvels J
    Br J Pharmacol; 1971 Jun; 42(2):281-6. PubMed ID: 5091160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydronorharmane modulates the depolarisation-induced efflux of 5-hydroxytryptamine and dopamine and is released by high potassium concentration from rat brain slices.
    Rommelspacher H; Subramanian N
    Eur J Pharmacol; 1979 Jun; 56(1-2):81-6. PubMed ID: 467516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
    Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptoline inhibition of serotonin uptake in rat forebrain homogenates.
    Keller KJ; Elliott GR; Holman RB; Vernikos-Danellis J; Barchas JD
    J Pharmacol Exp Ther; 1976 Sep; 198(3):619-25. PubMed ID: 978463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 6-methoxytetrahydro-beta-carboline on 5-hydroxytryptamine binding in rat brain.
    Taylor DL; Silverman PB; Ho BT
    J Pharm Pharmacol; 1984 Feb; 36(2):125-7. PubMed ID: 6143800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiochemical aspects of maprotiline (Ludiomil) action.
    Baumann PA; Maître L
    J Int Med Res; 1979; 7(5):391-400. PubMed ID: 387493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Carbolines: a tool for investigating structure-activity relationships of the high-affinity uptake of serotonin, noradrenaline, dopamine, GABA and choline into a synaptosome-rich fraction of various regions from rat brain.
    Rommelspacher H; Strauss SM; Rehse K
    J Neurochem; 1978 Jun; 30(6):1573-8. PubMed ID: 670999
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-hydroxy-3-ethylamino-2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine: evidence that methamphetamine does not induce the hydroxyl radical-mediated oxidation of serotonin.
    Yang Z; Wrona MZ; Dryhurst G
    J Neurochem; 1997 May; 68(5):1929-41. PubMed ID: 9109519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of cinepazide on the content, biosynthesis and turnover of noradrenaline, dopamine and 5-hydroxytryptamine in the rat brain under room air and hypoxia.
    Miwa S; Fujiwara M; Lee K; Fujiwara M
    Jpn J Pharmacol; 1986 May; 41(1):109-15. PubMed ID: 2426499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the reuptake of serotonin by tryptoline.
    Rommelspacher H; Bade P; Coper H; Kossmehl G
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):93-5. PubMed ID: 934360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central action of 6-hydroxytryptamine in rats.
    Jamrozik-Kruk Z; Brus R
    Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in regional brain levels of tryptophan, 5-hydroxytryptamine, 5-hydroxyindoleacetic acid, dopamine and noradrenaline after pinealectomy in the rat.
    Sugden D; Morris RD
    J Neurochem; 1979 May; 32(5):1593-5. PubMed ID: 571458
    [No Abstract]   [Full Text] [Related]  

  • 14. Para-substituted amphetamines and brain serotonin.
    Magyar K; Knoll J
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):139-43. PubMed ID: 1208223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-hydroxytryptamine uptake blockers on the concentration in brain of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male rats, pro-oestrous rats and ovariectomized rats treated with oestrogen and progesterone.
    Horn AM; Watts AG
    J Endocrinol; 1985 Mar; 104(3):407-13. PubMed ID: 2579182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model of central chemical 'serotoninectomy' in mice.
    Herman ZS; Bonczek A
    Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat.
    Pifl C; Pichler L; Kobinger W; Hornykiewicz O
    Eur J Pharmacol; 1988 Aug; 153(1):33-44. PubMed ID: 2463928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V; Davies JE; Hertting G; Placheta P
    Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injection of streptozotocin.
    Ding A; Nitsch R; Hoyer S
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):103-9. PubMed ID: 1370067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.
    Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F
    Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.